Transbilayer phosphatidylethanolamine (PtdEtn) movements in the plasma membrane of Saccharomyces cerevisiae are regulated by an ATP-dependent, protein-mediated process(es). To examine whether this process is influenced by the actin cytoskeleton, we have studied the PtdEtn translocation in S. cerevisiae cells after treatment with microfilament disrupting and microtubule-disrupting agents. PtdEtn translocation was studied by measuring the external PtdEtn levels, using fluorescamine as the external membrane probe, in the ATP-depleted, ATP-depleted and repleted, and N-ethylmaleimide-treated cells. The microfilaments and microtubules were disrupted by treatment with various cytochalasins and colchicine (or benomyl) respectively PtdEtn translocation became abnormal in the cytochalasin-treated cells but not in cells that were treated with microtubule-disrupting agents, such as colchicine or benomyl. These results have been interpreted to suggest that the actin cytoskeleton is involved in regulating the PtdEtn translocase activity in the yeast cell plasma membrane.
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Transbilayer movement of membrane phospholipids is a funEarlier studies from our laboratory have shown that the external PtdEtn levels in the yeast cell plasma membrane are regudamental process of cellular membrane biogenesis and cell lated by an ATP-dependent, protein-mediated process(es) [6] , growth [1, 2] . Although phospholipids, such as phosphatidic which has been further confirmed by other investigators [7] . In acid and phosphatidylglycerol can translocate spontaneously becontinuation of this work, we have now examined the role, if tween the two leaflets of the membrane bilayer in their protonany, of the actin cytoskeleton in regulating the transbilayer ated form, flip-flop of charged phospholipids, such as PtdEtn distribution in the plasma membrane of yeast cells. Here, phosphatidylethanolamine (PtdEtn) and phosphatidylserine we report that the external PtdEtn levels are significantly influ-(PtdSer), does not occur at an appreciable rate in artificial memenced by disrupting the actin cytoskeleton in these cells. branes [2] . Nevertheless, transbilayer movement of phospholipids must occur at considerable rates in membranes of living cells, particularly those endowed with a lipid biosynthetic capability.
MATERIALS AND METHODS

A number of hypotheses have been put forward concerning
Materials. Yeast extract and mycological peptone (peptone the mechanism of rapid flip-flop of lipids, but the most persua-M) were obtained from HiMedia Laboratories. Yeast Nitrogen sive is the postulate that flip-flop is catalyzed by specific pro-Base was from Difco Laboratories. Fluorescamine, sodium teins, termed as flippases or phospholipid translocases [2] . It is azide, N-ethylmaleimide, digitonin, the ATP estimation kit (366-possible to define two broad classes of flippases those operating UV), cytochalasin B, D and E, benomyl and colchicine were on phospholipids and glycolipids in biogeneic membranes, and purchased from Sigma Chemical Company. those operating at the plasma membranes of eukaryotic cells [2] .
Yeast Strains and Growth Conditions. Saccharomyces While the former class appears to facilitate translocation of lip-cerevisiae DBY 1690/3b strain (MatA, ade2Ϫ1, ACT ϩ ) is the ids between the two leaflets without any apparent energy input, laboratory isolate, (haploid) from the diploid strain DBY 1690 the latter class consists of the translocators that are driven by which was a kind gift from Dr David Botstein (Stanford Univerhydrolysis of ATP. Furthermore, numerous studies on blood cells sity, USA.) Cells were grown at 23°C in 1% mass/vol. yeast suggest that the inner distributions of PtdEtn and PtdSer in mem-extract, 2 % mass/vol. peptone M, 2% mass/vol. dextrose, branes could perhaps be stabilized by their interactions with the pH 5.5 (YEPD medium), and harvested at the late log phase. underlying cytoskeletal proteins [1, 3Ϫ5] .
Fluorescamine labeling. Late-log-phase cells were harvested by centrifuging at 1000ϫg for 5 min (23°C). The pellet Cytochalasin E treatment. In a separate set of experiments, the cells were treated with different concentrations of CE and For the labeling of total cellular aminophospholipids in yeast cells, the cells were made leaky by vortexing with 0.5 % digi-external PtdEtn was estimated. Typically, 1ϫ10 8 /ml cells were suspended in 0.67 % yeast nitrogen base, 2% dextrose, pH 5.5, tonin for 30 min at 30°C in an Eppendorf vibrato-mixer [8], then processed for fluorescamine labeling. medium and to it was added CE in Me 2 SO to final concentrations of 5, 10, 15, 20 and 40 µg/ml separately. Equal volumes Lipids were extracted using 2 :1 (by vol.) chloroform/methanol [9] and individual phospholipid components were separated of Me 2 SO were added to the control cells. The mixtures were incubated for 3 h at 23°C. Portions of the cell suspension were by two-dimensional TLC on coated aluminium-backed silica gel G-60 plates (Merck), as described earlier [6] . The plates were taken out after CE treatment, washed with 0.67% yeast nitrogen base, 2% dextrose, pH 5.5, and incubated without any drug for stained with iodine vapors and the spots corresponding to the various phospholipids cut out carefully. Lipid phosphate was es-another 3 h at 23°C. The cells were harvested, washed with buffer A, then processed for fluorescamine labeling. timated according to the method of Bartlett [10] .
N-Ethylmaleimide/sodium azide treatments. Cells Effect of ATP depletion/repletion in cytochalasin-treated cells. Cells (1ϫ10 8 /ml) were treated first with CE (10 g/ml) as (2ϫ10 8 ) were treated with 9 mM N-ethylmaleimide or 20 mM sodium azide following the published procedure [6] , then pro-described above, then incubated in 0.67% yeast nitrogen base, 2% dextrose, pH 5.5, in the presence of 20 mM sodium azide cessed for fluorescamine labeling.
Cellular ATP depletion and repletion. For the depletion of (3 h, 23°C) as well as in its absence (16 h, 23°C), as described above. A small portion of the cells, after 16 h incubation, was total cellular ATP pools, cells were incubated in 0.67 % yeast nitrogen base (Difco), 2% sorbitol, pH 5.5 (Difco) for 16 h at washed with 0.67% yeast nitrogen base, 2% dextrose, pH 5.5, and incubated for 3 h at 23°C to replete the cellular ATP. The 23°C. To it was added 2 % dextrose and the mixture incubated for another 3 h at 23°C to replete the cellular ATP pools. Sam-cells harvested after CE treatment, sodium azide treatment, ATP depletion and ATP repletion were washed with buffer A, then ples (about 2ϫ10 8 cells) were taken out at 0 h depletion, 16 h depletion and after 3 h repletion, and processed for fluorescam-processed for fluorescamine labeling.
In another set of experiments, the cells were treated with CE ine labeling as described above.
ATP levels in cells were estimated using Sigma ATP estima-(5 µg/ml) followed by ATP depletion and repletion, then processed for fluorescamine labeling. tion kit (procedure no. 366-UV).
Treatment with microfilament disrupting agents. Cells Treatment with microtubule-disrupting agents. Cells (1ϫ10 8 /ml) were suspended in 0.67% yeast nitrogen base, 2% (1ϫ10 8 /ml) were suspended in 0.67% yeast nitrogen base dextrose, pH 5.5, and then treated separately with benomyl (50 µg/ml) and colchicine (5 mg/ml) in Me 2 SO for 4 h and 6 h, at 23°C. Equal volume of Me 2 SO was added to the control cells. The cells were harvested, washed with buffer A and processed for fluorescamine labeling.
Viability Measurement. A portion of the cell suspension was taken out before fluorescamine labeling in each experiment. The cells were washed and suspended in methylene blue dye solution as described earlier [11] . Blue-stained cells were considered as dead cells and counted using haemocytometer to ex- Fluorescence microscopy. Cells labeled with fluorescamine, 40 µg/ml) for 3 h, then labeled with fluorescamine. A portion of the after various treatments as described above, were spread over cells was washed twice with 0.67% yeast nitrogen base, 2% sucrose and poly-L-lysine-coated glass slides and mounted under coverslip. incubated without any drug for another 3 h, then processed for fluoresThey were viewed under Leica (Wild Leitz) fluorescence micro-camine labeling. Control cells were incubated for 6 h under identical scope. Photographs were taken using Kodak ASA 400 film. . Earlier studies from our laboratory have shown that the fluorescamine can selectively modify the PtdEtn located in the was modified at 10°C, about 75Ϫ80% of this phospholipid was outer surface of the intact yeast cells [6] . Selection of this rea-labeled by fluorescamine at 37°C or upon permeabilizing the gent to probe the external aminophospholipids was based on the cells with digitonin (Fig. 1 a) . These results clearly establish the fact that the cytoplasmic pH (Ϸ6.6) in the yeast cells [15] is suitability of fluorescamine as an external membrane probe to significantly lower than the optimal pH (Ϸ8.0) required for the determine the aminophospholipid (especially PtdEtn) distribufluorescamine labeling [16] . To further establish that this reagent tion in the yeast cells. does modify only the external PtdEtn in the yeast cell plasma membrane, the intact cells were labeled with fluorescamine at Characterization of the PtdEtn translocation process across the yeast plasma membrane. Earlier studies have demonstrated 10°C, 37°C and 10°C, but after permeabilizing the cells with digitonin (Fig. 1) . Whereas only about 6.6 % of the total PtdEtn the involvement of an ATP-dependent, protein-mediated pro- removing CE from the incubation medium (Fig. 4) . However, the PtdEtn distribution could not be reversed in the cells that were treated with a high CE concentration (40 µg/ml).
cess(es) in regulation of PtdEtn distribution across the plasma
Effect of ATP depletion/repletion on the external PtdEtn membrane bilayer of the S. cerevisiae A184D cells [6] . To examlevels in the CE-treated cells. To examine whether the PtdEtn ine whether S. cerevisiae DBY 1690/3b cells possess a similar levels could be further reduced in the CE-(5 µg/ml)-treated cells PtdEtn-translocation process, the PtdEtn distribution was anaby depleting the cellular ATP, the cytochalasin-treated cells were lysed in ATP-depleted, ATP-depleted and repleted, and N-ethylsubjected to sodium azide or starved both in the presence and maleimide-treated cells. The ATP depletion was carried out by absence of CE (5 µg/ml), then the outer PtdEtn levels analyzed. both sodium azide treatment and metabolic starvation. The
The PtdEtn levels decreased to about 50% after depleting the amounts of external PtdEtn decreased by 40Ϫ50% after treating cells of ATP (Fig. 5) . The external PtdEtn levels, however, rethe cells with sodium azide (Fig. 2) . Similar results were obturned to their original levels by repleting the cells of ATP. From served when the cells were depleted of ATP by metabolic starvathese results, we infer that the biochemical loci affected by the tion (Fig. 2) . The external PtdEtn levels in the ATP-depleted ATP depletion and CE treatments are plausibly the same. cells could, however, be restored to near normal by repleting the cells of ATP (Fig. 2) . These results strongly indicate that the Effect of microtubule-disrupting agents on the outer plasma PtdEtn distribution in these cells is regulated by an ATP-depen-membrane PtdEtn levels. To further examine whether the obdent process(es). That this process is mediated by some proteinserved decrease in PtdEtn levels in the cytochalasin-treated cells like factor(s) was revealed by our observation that the external is caused by disruption of the microfilaments only, the PtdEtn PtdEtn levels were decreased by 60Ϫ70% after treating the distribution was examined in yeast cells that were treated with cells with the sulfhydryl-modifying reagent, N-ethylmaleimide microtubule-disrupting agents, namely benomyl and colchicine (Fig. 2) .
[21Ϫ24]. The microtubule disruption did not significantly affect the external PtdEtn levels in the yeast cells (Fig. 6 ). Effect of cytoskeleton-disrupting agents on the PtdEtn distribution. Effect of actin filament-disrupting agents (cytochalasins) on outer plasma membrane PtdEtn levels. Cytochalasins DISCUSSIONS have been extensively used to disrupt the actin cytoskeleton in a variety of eukaryotic cells [17, 18] . These compounds not only Various phospholipids in biological membranes are differentially distributed in the two-halves of the membrane bilayer. induce depolymerization of actin filaments, but also prevent their growth [19] . We therefore considered it of interest to ana-While the choline-containing phospholipids tend to localize mainly in the outer monolayer, the aminophospholipids are prelyze the PtdEtn distribution in the yeast cells that were treated with various cytochalasins (Fig. 3) . The external PtdEtn levels sent largely in the inner monolayer [1] . Since about 60% of the total phospholipids have been reported to belong to the yeast decreased by at least 50% in the yeast cells that were treated with CB, CD or CE. Furthermore, no decrease in the ATP levels cell plasma membrane [25Ϫ28], present results indicate that about 90% of the total plasma membrane PtdEtn is present in [20] and total phospholipid compositions were observed in the CB-treated cells (data not shown).
the inner monolayer and that the remaining 10% is present in the outer monolayer, which is consistent with earlier findings To examine whether the cytochalasins produce concentration-dependent effects on the outer membrane PtdEtn levels, the [6, 29] . Furthermore, it reconfirms that the transbilayer PtdEtn movements in the yeast cell plasma membrane are regulated by cells were treated with different concentrations of CE. The external PtdEtn levels gradually decreased with an increase in the CE an ATP-dependent, protein-mediated process(es). However, unlike earlier study [29], we could not detect PtdSer in the external concentration. That this decrease in the PtdEtn levels is not be- This study shows that a treatment with microfilament-dis- microtubule-disrupting agents such as colchicine [21, 22] or befor the isolation and purification of total lipids from animal tissue, nomyl [23, 24] . That the decreased external PtdEtn levels in the
